TMP/SMX vs placebo, no treatment or non‐PCP drug: All‐cause mortality ‐ sensitivity analysis
TMP/SMX showed no clear difference in all cause mortality ‐ TMP/SMX versus placebo or no treatment compared with placebo, no treatment or non‐PCP drug (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
TMP/SMX vs placebo, no treatment or non‐PCP drug All cause mortality ‐ TMP/SMX versus placebo or no treatment · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients TMP/SMX showed no clear difference in all cause mortality ‐ TMP/SMX versus placebo or no treatment compared with placebo, no treatment or non‐PCP drug (low certainty). Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients (2014) · Cochrane Headline outcomes only | RR 0.58 [0.17, 2] | 4 studies · 461 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients 2014 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.